Status Asthmaticus on the Intensive Care Prospective - STATIC PRO
NCT ID: NCT02936778
Last Updated: 2019-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
221 participants
OBSERVATIONAL
2016-08-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
NCT01403428
Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
NCT01188473
Status Asthmaticus on the PICU; Intravenous Salbutamol
NCT03493503
A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status Asthmaticus
NCT02539420
Physiotherapy for Infants With Bronchiolities
NCT03575091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PICU (= case group)
Children aged 2-18 years admitted to a Paediatric Intensive Care Unit in the Netherlands, with a diagnosis of acute wheeze or SAA.
No interventions assigned to this group
MC (= control group)
Children aged 2-18 years admitted to a Medium Care in the Netherlands, with a diagnosis of acute wheeze or SAA.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to a PICU for SAA or acute wheeze or admission to a MC for SAA or acute wheeze
Exclusion Criteria
* Down's Syndrome
* Congenital/acquired heart defect that interferes with normal SAA treatment
* Congenital/acquired airway defect (tracheomalacia/bronchomalacia)
* Primary/secondary immunodeficiency
* Pre-existing chronic pulmonary condition, known to mimic asthma: Cystic Fibrosis, Bronchopulmonary dysplasia, Bronchiolitis obliterans
* If both parents are not able to speak the Dutch language
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Radboud University Medical Center
OTHER
Maasstad Hospital
OTHER
Amsterdam UMC, location VUmc
OTHER
UMC Utrecht
OTHER
University Medical Center Groningen
OTHER
Amphia Hospital
OTHER
Rijnstate Hospital
OTHER
Tergooi Hospital
OTHER
Maastricht University Medical Center
OTHER
Leiden University Medical Center
OTHER
Erasmus Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthijs de Hoog
Prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasmus MC
Rotterdam, South Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL52508.078.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.